|
Do you want to know the innovation generated by Lipopharma ? |
Go to Lipopharma technology portfolio |
|
About Lipopharma | Our technology portfolio | Our innovation policy |
|
|
Do you want to know the innovation generated by EntreChem SL ? |
Go to EntreChem SL technology portfolio |
|
|
About EntreChem SL | Our technology portfolio | Our innovation policy |
|
|
Do you want to know the innovation generated by Biopol’H ? |
Go to Biopol’H technology portfolio |
|
|
About Biopol’H | Our technology portfolio | Our innovation policy |
|
Versatile platform to bind transition metals to a wide range of biomolecules that allows to obtain bioconjugated radiopharmaceuticals for diagnostic and therapeutic purposes (cheaper and time-saving alternative to the current methods)
Vendor Organization : Universitat Autònoma de Barcelona / Spain 
Type of Organization : Research group (university, research center)
Type of Tech Offer : Technology
Current Development Status : Proof of Concept or Laboratory Prototype
Required business relationship : License agreement , Technical cooperation - further development
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences, Chemistry
Tags : nuclear medicine, radiopharmaceutical, oncology, transition metals
Design of new antitumoral agents based on a technological platform based on oncolytic adenoviruses
Vendor Organization : VCN Biosciences / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : Other
Required business relationship : Joint venture agreement , Technical cooperation - further development
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences, Chemistry
Tags : oncology, Biotechnology, Oncolytic viruses, Pancreatic Cancer, antitumoral, adenoviruses, tumor cells, clinical studies, chemotherapeutic drugs, cancer drugs,
Minerval: potential to become effective treatment against some of the most lethal forms of cancer
Vendor Organization : Lipopharma / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : In Use Testing Results Available
Required business relationship : License agreement , Technical cooperation - further development , Technical cooperation - testing of new applications , Technical cooperation - adaptation to specific needs
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences
Tags : membrane lipid therapy, lipid, membrane, cancer, oncology, minerval,
PUFA derivative with significant anti-inflammatory activity
Vendor Organization : Lipopharma / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : In Use Testing Results Available
Required business relationship : License agreement , Technical cooperation - further development , Technical cooperation - testing of new applications , Technical cooperation - adaptation to specific needs
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences
Tags : membrane lipid therapy, lipid, membrane, cancer, oncology, anti-inflammatory activity
Polyunsaturated fatty acid derivative that is showing superior activity against neuronal death in cellular models
Vendor Organization : Lipopharma / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : In Use Testing Results Available
Required business relationship : License agreement , Technical cooperation - further development , Technical cooperation - testing of new applications , Technical cooperation - adaptation to specific needs
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences
Tags : membrane lipid therapy, lipid, membrane, cancer, oncology, alzheimer's disease
Drug D&D: inhibitor of VEGF and c-myc by modulation of sp1 transcription factor
Vendor Organization : EntreChem SL / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : Research or Experimental
Required business relationship : License agreement , Joint venture agreement , Technical cooperation - further development , Technical cooperation - testing of new applications
Sector : Biotechnology, Pharmaceutical, Healthcare, Chemical
Domains of Knowledge : Life sciences, Chemistry
Tags : drugs, cancer, oncology, kinase inhibitor, Ikkb, Ikk2, NF-kB, VEGF, c-myc, genetic engineering, chiral building blocks
Drug D&D: Novel Ikkb kinase inhibitor for the NF-kB signal transduction pathway.
Vendor Organization : EntreChem SL / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Technology
Current Development Status : Research or Experimental
Required business relationship : License agreement , Joint venture agreement , Technical cooperation - further development , Technical cooperation - testing of new applications
Sector : Biotechnology, Pharmaceutical, Healthcare, Chemical
Domains of Knowledge : Life sciences, Chemistry
Tags : drugs, cancer, oncology, kinase inhibitor, Ikkb, Ikk2, NF-kB, VEGF, c-myc, genetic engineering, chiral building blocks
Chiral Building Blocks and Pharmaceutical Intermediates: Optically pure Amino Alcohols and Diamines
Vendor Organization : EntreChem SL / Spain
Type of Organization : Spin off, Start up
Type of Tech Offer : Product
Current Development Status : In Use Testing Results Available
Required business relationship : Commercial agreement
Sector : Biotechnology, Pharmaceutical, Healthcare, Chemical
Domains of Knowledge : Life sciences, Chemistry
Tags : drugs, cancer, oncology, kinase inhibitor, Ikkb, Ikk2, NF-kB, VEGF, c-myc, genetic engineering, chiral building blocks
Advertisers
Advertisers
Advertisers
Advertisers
